Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Cour Pharmaceutical Development Company, Inc.

Clinical trials sponsored by Cour Pharmaceutical Development Company, Inc., explained in plain language.

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

New drug aims to control type 1 diabetes early

Disease control Recruiting now

This study tests a new drug, CNP-103, in people aged 12 to 35 who were diagnosed with stage 3 type 1 diabetes within the last 6 months. The goal is to see if the drug is safe and can help control the disease. Participants will receive either the drug or a placebo, and researchers…

Phase: PHASE1, PHASE2 • Sponsor: COUR Pharmaceutical Development Company, Inc. • Aim: Disease control

Last updated Jun 27, 2026 14:01 UTC